# Acute Labetalol Use in Preeclampsia

> **NCT03872336** · PHASE4 · TERMINATED · sponsor: **Albany Medical College** · enrollment: 15 (actual)

## Conditions studied

- Preeclampsia With Severe Features

## Interventions

- **DRUG:** Experimental labetalol dose
- **OTHER:** Current standard of care

## Key facts

- **NCT ID:** NCT03872336
- **Lead sponsor:** Albany Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-18
- **Primary completion:** 2020-07-20
- **Final completion:** 2020-07-20
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2020-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03872336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03872336, "Acute Labetalol Use in Preeclampsia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03872336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*